Dr. Aurora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2799 W Grand Blvd
Detroit, MI 48202Phone+1 313-916-2600
Summary
- Dr. Lindsey Aurora completed Internal Medicine residency followed by a Chief Medical Resident year at Henry Ford Hospital (HFH) in Detroit, Michigan. Thereafter, she pursued General Cardiology fellowship at HFH and also served as a Chief Fellow. She completed Advanced Heart Failure and Transplant Fellowship at University of Michigan and re-joined HFH as staff. Dr. Aurora has a strong interest in cardiogenic shock, left ventricular assist devices and inherited cardiomyopathies. She enjoys staying active in research and teaching/working alongside medical trainees!
Education & Training
- University of MichiganFellowship, Advanced Heart Failure and Transplant Cardiology, 2022 - 2023
- Henry Ford Health/Henry Ford HospitalFellowship, Cardiovascular Disease, 2019 - 2022
- Henry Ford Health/Henry Ford HospitalChief Residency, Internal Medicine, 2018 - 2019
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2015 - 2018
- Wayne State University School of MedicineClass of 2015
Certifications & Licensure
- MI State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Board of Nuclear CardiologyNuclear Cardiology Certification
- ECMO Specialist Training CourseUniversity of Michigan
- National Board of EchocardiographyAdult Echocardiography Certification
Awards, Honors, & Recognition
- Outstanding Fellow of The Year Nominee Division of Cardiology, Henry Ford Hospital, 2022
- Outstanding Service Award, Cardiology Division Division of Cardiology, Henry Ford Hospital, 2021-2022
Clinical Trials
- Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM Start of enrollment: 2023 Jun 19
- Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM Start of enrollment: 2023 Aug 30
- Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction Start of enrollment: 2023 Dec 20
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsRisk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides.Alexander T Michaels, Lindsey Aurora, Edward L. Peterson, Bin Liu, Yigal M. Pinto
Journal of Cardiac Failure. 2020-01-01 - 133 citationsCardiac Tamponade Secondary to COVID-19.Mohammed Dabbagh, Lindsey Aurora, Penny L D'Souza, Allison Weinmann, Pallavi Bhargava
JACC. Case Reports. 2020-07-15 - 3 citationsPrognostic Utility of the HEART Score in the Observation Unit.Alexander T Michaels, Joseph Gibbs, Sagger Mawri, George Dirani, Lindsey Aurora
Critical Pathways in Cardiology. 2018-12-01
Journal Articles
- Going with the flow: device therapy for heart failure complicated by cardiorenal syndromeAurora L, Grafton G, Cowger J., J Card Fail. 2024:S1071-9164(24)00066-6
- Signaling pathways in hypertrophic cardiomyopathy: will proteomic profiling guide the future?Aurora L, Wanderley MRB Jr., J Card Fail. 2024;30:473-475.
- Defining the problem, the first step to making progress in acute myocardial infarction and cardiogenic shock care.Basir MB, Gorgis S, Aurora L, Cardiovasc Revasc Med. 2024:S1553-8389(24)00108-8.
- Join now to see all
Books/Book Chapters
Professional Memberships
- Heart Failure Society of America (HFSA)Member
- International Society for Heart and Lung Transplantation (ISHLT)Member
- Member
- Gold Humanism Honor SocietyMember
- Member
Other Languages
- Hindi, Punjabi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: